Seattle institute shares favorable results for malaria vaccine

06/30/2009 | Seattle Times, The

Researchers at Seattle Biomedical Research Institute have successfully engineered the genes of malaria-carrying parasites and used these to create an experimental vaccine that proved 100% effective in tests on rats and mice. The researchers plan to test the vaccine candidate on humans next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX